🔎 Trials Near Me

Akèy › Atrofi miskilè spinal › Texas

Etid klinik pou Atrofi miskilè spinal nan Texas

10 etid pou Atrofi miskilè spinal ap chèche patisipan nan sit nan Texas.

Vil nan Texas

Tèks ofisyèl etid la (Anglè)

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

  • The University of Texas Southwestern Medical Center at Dallas, Dallas
  • Cook Children's Jane and John Justin Neurosciences Center, Fort Worth
Ap rekriteFaz 4
3 Months – 24 Months · Tout sèks · Mizajou Oct 2, 2026 · NCT05861986

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

  • University of Texas Southwestern Medical Center, Dallas
  • Neurology Rare Disease Center, Flower Mound
  • Cook Children's Medical Center, Fort Worth
  • ak 1 plis
Ap rekriteFaz 2
Jiska laj 2 · Tout sèks · Mizajou Oct 2, 2026 · NCT07047144

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

  • Neurology Rare Disease Center, Flower Mound
  • Texas Children's Hospital, Houston
Ap rekriteFaz 2
Laj 5 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT07287982

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy

  • University of Texas Southwestern Medical Center, Dallas
Ap rekriteFaz 4
3 Months – 24 Months · Tout sèks · Mizajou Sep 10, 2026 · NCT05861999

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy

  • Texas Children's Hospital, Houston
Ap rekrite
Laj 3 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05866419

A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

  • Neurology Rare Disease Center, Flower Mound
Ap rekriteFaz 3
0 Days – 42 Days · Tout sèks · Mizajou Aug 18, 2026 · NCT07221669

A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec

  • Neurology Rare Disease Center, Flower Mound
Ap rekriteFaz 3
0 Days – 7 Months · Tout sèks · Mizajou Aug 11, 2026 · NCT07444450

Clinical Procedures to Support Research in ALS

  • University of Texas San Antonio Health Science Center, San Antonio
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03489278

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

  • Cook Children's, Fort Worth
  • Texas Children's Hospital, Houston
  • CHRISTUS Health, San Antonio
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jan 31, 2025 · NCT04174157

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.